Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (620)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
83
2022
276
13.890
 Why?
Papillomavirus Infections
18
2021
163
3.010
 Why?
Ovarian Neoplasms
35
2023
472
2.730
 Why?
Uterine Cervical Dysplasia
16
2017
51
2.590
 Why?
Endometrial Neoplasms
33
2019
144
2.550
 Why?
Carcinoma, Squamous Cell
30
2018
384
2.070
 Why?
Gene Expression Regulation, Neoplastic
18
2021
866
1.970
 Why?
Human papillomavirus 16
8
2019
48
1.860
 Why?
Gene Expression Profiling
9
2021
1138
1.600
 Why?
Female
183
2023
28418
1.590
 Why?
Papillomaviridae
16
2020
107
1.490
 Why?
DNA Methylation
21
2020
574
1.390
 Why?
Antineoplastic Combined Chemotherapy Protocols
16
2013
1056
1.340
 Why?
Human papillomavirus 18
5
2019
10
1.270
 Why?
Genital Neoplasms, Female
9
2018
38
1.250
 Why?
Humans
184
2023
54246
1.150
 Why?
Adult
87
2020
14182
1.100
 Why?
Neoplasm Staging
40
2019
806
1.090
 Why?
Adenocarcinoma
18
2018
428
1.060
 Why?
Middle Aged
93
2020
13070
1.030
 Why?
Polymorphism, Single Nucleotide
10
2019
552
1.020
 Why?
Fluorodeoxyglucose F18
15
2022
205
1.010
 Why?
MicroRNAs
7
2019
386
0.990
 Why?
DNA-Binding Proteins
9
2021
462
0.990
 Why?
Genetic Predisposition to Disease
12
2018
570
0.980
 Why?
Carcinoma
12
2010
153
0.960
 Why?
Neoplasm Recurrence, Local
17
2013
644
0.940
 Why?
Oncogene Proteins, Viral
4
2019
57
0.910
 Why?
Cervix Uteri
7
2017
53
0.850
 Why?
Radiopharmaceuticals
14
2022
238
0.840
 Why?
Repressor Proteins
4
2019
165
0.840
 Why?
Alphapapillomavirus
1
2021
16
0.810
 Why?
DNA, Viral
6
2019
142
0.790
 Why?
Cell Line, Tumor
18
2021
1550
0.760
 Why?
Immunologic Factors
2
2014
130
0.760
 Why?
Genetic Markers
8
2017
117
0.720
 Why?
Neoplasm Invasiveness
13
2020
295
0.720
 Why?
Genes, Tumor Suppressor
8
2007
85
0.710
 Why?
Immunoglobulins
3
2017
89
0.700
 Why?
Neoplasm Proteins
10
2019
359
0.690
 Why?
Neoplasms
7
2022
1315
0.690
 Why?
Genomics
4
2018
310
0.670
 Why?
Biomedical Research
1
2022
240
0.670
 Why?
Gene Silencing
5
2018
129
0.660
 Why?
Aged
65
2020
10041
0.640
 Why?
Vascular Endothelial Growth Factor A
2
2017
230
0.580
 Why?
Proteomics
1
2019
343
0.570
 Why?
Cisplatin
7
2022
352
0.570
 Why?
HLA-C Antigens
2
2018
4
0.560
 Why?
Receptors, KIR
2
2018
15
0.560
 Why?
Promoter Regions, Genetic
12
2020
520
0.550
 Why?
Tumor Virus Infections
4
2006
43
0.530
 Why?
Ubiquitin Thiolesterase
2
2021
23
0.530
 Why?
Microsatellite Repeats
14
2007
46
0.530
 Why?
Positron-Emission Tomography
11
2013
322
0.530
 Why?
Lymph Nodes
10
2010
284
0.520
 Why?
Hysterectomy
15
2022
88
0.520
 Why?
Gynecologic Surgical Procedures
4
2010
31
0.520
 Why?
Disease-Free Survival
17
2013
485
0.520
 Why?
Phenotype
4
2016
820
0.480
 Why?
Aged, 80 and over
33
2019
3429
0.480
 Why?
Prognosis
19
2021
2118
0.470
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.470
 Why?
Alleles
5
2017
277
0.460
 Why?
Nuclear Proteins
8
2009
252
0.460
 Why?
Lymphatic Metastasis
12
2019
256
0.440
 Why?
Ovary
2
2008
105
0.440
 Why?
Genotype
9
2018
599
0.420
 Why?
Membrane Proteins
3
2005
389
0.420
 Why?
STAT3 Transcription Factor
3
2021
87
0.420
 Why?
Cell Movement
5
2021
271
0.420
 Why?
Peritoneal Neoplasms
4
2008
60
0.420
 Why?
Ultrasonic Therapy
3
2001
40
0.410
 Why?
Carcinoma, Endometrioid
6
2014
41
0.410
 Why?
Loss of Heterozygosity
9
2007
97
0.410
 Why?
Genes, p53
2
2010
60
0.410
 Why?
Survival Analysis
13
2021
735
0.400
 Why?
Cell Proliferation
6
2021
1096
0.390
 Why?
Uterine Neoplasms
5
2009
63
0.390
 Why?
Risk Factors
13
2019
3930
0.380
 Why?
Ascites
2
2008
28
0.380
 Why?
Signal Transduction
8
2021
1753
0.380
 Why?
Carboplatin
2
2009
62
0.380
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
14
0.370
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
24
0.370
 Why?
GTPase-Activating Proteins
1
2009
23
0.360
 Why?
Membrane Glycoproteins
2
2009
269
0.360
 Why?
Disease Progression
6
2020
913
0.360
 Why?
Antineoplastic Agents
9
2014
1300
0.360
 Why?
Mutation
12
2018
1501
0.360
 Why?
Base Sequence
8
2019
719
0.360
 Why?
Antibodies, Monoclonal
5
2021
562
0.350
 Why?
Matrix Metalloproteinase 9
1
2009
93
0.350
 Why?
Neoplasms, Glandular and Epithelial
3
2006
48
0.350
 Why?
Brachytherapy
9
2014
42
0.350
 Why?
Proto-Oncogene Proteins c-myc
2
2021
55
0.340
 Why?
DNA, Neoplasm
10
2006
171
0.340
 Why?
Abdominal Neoplasms
1
2009
19
0.340
 Why?
Laser Coagulation
1
2009
27
0.340
 Why?
Combined Modality Therapy
11
2010
692
0.340
 Why?
DNA Repair
11
2007
202
0.340
 Why?
Homeodomain Proteins
2
2006
82
0.330
 Why?
Microsatellite Instability
5
2019
20
0.320
 Why?
Protozoan Proteins
1
2008
31
0.320
 Why?
RNA-Binding Proteins
2
2021
136
0.320
 Why?
Cohort Studies
12
2019
1543
0.320
 Why?
Drug Administration Schedule
9
2013
401
0.310
 Why?
Laparoscopy
3
2022
188
0.310
 Why?
Drug Resistance, Neoplasm
6
2016
309
0.310
 Why?
Kaplan-Meier Estimate
6
2019
514
0.310
 Why?
Ovariectomy
7
2010
125
0.310
 Why?
Chromosomes, Human, Pair 11
2
2005
54
0.300
 Why?
Antigens, CD
2
2007
242
0.300
 Why?
Chromosomes, Human, Pair 3
4
2001
20
0.300
 Why?
SOXC Transcription Factors
2
2019
14
0.300
 Why?
Retrospective Studies
31
2022
6432
0.300
 Why?
Heart Arrest
1
2009
159
0.290
 Why?
Topotecan
5
2013
19
0.290
 Why?
Polymerase Chain Reaction
9
2010
531
0.290
 Why?
POU Domain Factors
1
2006
1
0.290
 Why?
Vulvar Neoplasms
5
2002
54
0.280
 Why?
Registries
6
2010
553
0.280
 Why?
HeLa Cells
3
2021
291
0.270
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
474
0.270
 Why?
Deoxycytidine
3
2006
28
0.270
 Why?
Anemia
3
2020
84
0.270
 Why?
Vaginal Smears
6
2006
31
0.270
 Why?
Survival Rate
10
2009
951
0.260
 Why?
Young Adult
7
2018
4308
0.260
 Why?
Breast Neoplasms
5
2018
1248
0.260
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
673
0.240
 Why?
Chromosome Aberrations
1
2006
316
0.240
 Why?
Virus Integration
2
2021
9
0.240
 Why?
HSP70 Heat-Shock Proteins
1
2004
61
0.240
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
12
0.240
 Why?
Cystadenocarcinoma, Papillary
2
2002
15
0.240
 Why?
Oncostatin M
2
2021
5
0.240
 Why?
Quinazolines
1
2003
39
0.240
 Why?
Neoplasm Metastasis
4
2021
252
0.230
 Why?
Antigens, Neoplasm
1
2004
170
0.230
 Why?
Genome-Wide Association Study
2
2017
190
0.230
 Why?
Polymorphism, Genetic
5
2018
193
0.230
 Why?
Small Cell Lung Carcinoma
1
2023
27
0.230
 Why?
Omentum
1
2002
13
0.220
 Why?
Case-Control Studies
7
2019
1228
0.220
 Why?
Chromosome Deletion
3
2000
150
0.220
 Why?
Tumor Microenvironment
2
2021
209
0.220
 Why?
Linkage Disequilibrium
3
2017
47
0.220
 Why?
Neoadjuvant Therapy
2
2022
125
0.210
 Why?
Proto-Oncogene Proteins c-akt
2
2014
176
0.210
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.210
 Why?
CA-125 Antigen
3
2008
20
0.210
 Why?
Base Pair Mismatch
5
2006
24
0.210
 Why?
Chemoradiotherapy
1
2022
42
0.210
 Why?
Suction
1
2001
22
0.210
 Why?
Immunohistochemistry
11
2016
1089
0.210
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.210
 Why?
Genetic Variation
4
2019
253
0.210
 Why?
Antibodies, Monoclonal, Humanized
5
2013
240
0.210
 Why?
Postoperative Complications
3
2022
1033
0.210
 Why?
Treatment Outcome
22
2014
5604
0.210
 Why?
Radiotherapy, Conformal
2
2014
54
0.200
 Why?
Carcinoma in Situ
2
2013
74
0.200
 Why?
Colorectal Neoplasms
3
2002
235
0.200
 Why?
Adaptor Proteins, Signal Transducing
8
2007
208
0.200
 Why?
Antimetabolites, Antineoplastic
2
2002
39
0.200
 Why?
Proteins
5
2008
376
0.200
 Why?
Minority Groups
1
2022
135
0.190
 Why?
Fetofetal Transfusion
1
2020
5
0.190
 Why?
Pregnancy, Twin
1
2020
7
0.190
 Why?
Polycythemia
1
2020
11
0.190
 Why?
Smoking
1
2005
555
0.190
 Why?
Gene Regulatory Networks
2
2019
124
0.190
 Why?
Twins, Monozygotic
1
2020
17
0.190
 Why?
Lymph Node Excision
7
2019
140
0.190
 Why?
Radiotherapy
3
2010
138
0.190
 Why?
Genetic Diseases, Inborn
1
2000
26
0.190
 Why?
Sarcoma
3
2009
73
0.190
 Why?
Receptor, erbB-3
1
2020
1
0.190
 Why?
Furin
1
2020
3
0.190
 Why?
Transcriptome
2
2020
346
0.190
 Why?
Receptor, IGF Type 1
1
2020
19
0.190
 Why?
HLA-DQ Antigens
1
2000
4
0.190
 Why?
Phosphoproteins
2
2016
116
0.190
 Why?
Patient Satisfaction
2
2006
304
0.180
 Why?
Mice, Nude
4
2021
283
0.180
 Why?
RNA, Neoplasm
3
2007
54
0.180
 Why?
Tumor Cells, Cultured
7
2021
477
0.180
 Why?
Students
1
2022
207
0.180
 Why?
Tomography, X-Ray Computed
7
2013
1213
0.180
 Why?
Prenatal Diagnosis
1
2020
108
0.180
 Why?
Antibodies, Neoplasm
1
2019
35
0.180
 Why?
Papillomavirus E7 Proteins
2
2017
33
0.180
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
5
0.170
 Why?
Placenta
1
2020
135
0.170
 Why?
Adolescent
13
2018
6885
0.170
 Why?
Indocyanine Green
1
2019
39
0.170
 Why?
Doxorubicin
4
2009
259
0.170
 Why?
Salvage Therapy
3
2008
145
0.160
 Why?
Fallopian Tube Neoplasms
3
2008
19
0.160
 Why?
Cyclooxygenase 2
2
2017
49
0.160
 Why?
Decision Making
1
2001
290
0.160
 Why?
Reproducibility of Results
1
2022
1304
0.160
 Why?
HLA-B Antigens
1
2017
7
0.160
 Why?
HLA-DRB1 Chains
1
2017
8
0.160
 Why?
Sequence Analysis, DNA
1
2019
273
0.160
 Why?
Lung Neoplasms
2
2023
642
0.160
 Why?
DNA Copy Number Variations
1
2018
114
0.160
 Why?
Metabolic Networks and Pathways
1
2018
104
0.150
 Why?
Follow-Up Studies
12
2019
2387
0.150
 Why?
Receptors, Vitronectin
1
1997
1
0.150
 Why?
Transcription Factors
1
2021
622
0.150
 Why?
Carcinoma, Adenosquamous
3
2009
8
0.150
 Why?
Tumor Suppressor Proteins
3
2005
141
0.150
 Why?
Proto-Oncogene Proteins
5
2004
169
0.150
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
20
0.150
 Why?
Bayes Theorem
1
2017
123
0.150
 Why?
DNA Mutational Analysis
9
2005
217
0.150
 Why?
Adipose Tissue
1
2019
207
0.150
 Why?
In Situ Hybridization
3
2008
82
0.150
 Why?
Interleukin-10
1
2017
107
0.150
 Why?
Leukocytes, Mononuclear
1
2017
133
0.150
 Why?
Radiotherapy, Intensity-Modulated
2
2009
170
0.150
 Why?
Gene Expression Regulation, Viral
1
2017
50
0.150
 Why?
Protein Binding
1
2019
736
0.140
 Why?
Radiotherapy Dosage
8
2014
243
0.140
 Why?
Body Mass Index
3
2010
712
0.140
 Why?
Taxoids
3
2006
45
0.140
 Why?
ROC Curve
1
2017
259
0.140
 Why?
Animals
10
2021
14385
0.140
 Why?
Carrier Proteins
7
2006
359
0.140
 Why?
Colposcopy
3
2006
19
0.140
 Why?
Estrogens
1
2017
244
0.140
 Why?
Radiation Injuries
3
2008
153
0.140
 Why?
Biopsy
5
2006
692
0.130
 Why?
Prospective Studies
10
2019
2604
0.130
 Why?
Wound Healing
2
2018
228
0.130
 Why?
Carcinosarcoma
3
2019
18
0.130
 Why?
Risk Assessment
8
2019
1361
0.130
 Why?
Molecular Sequence Data
5
2009
980
0.130
 Why?
Protein Kinase Inhibitors
2
2014
216
0.130
 Why?
Ultrasonography, Doppler, Color
1
1995
35
0.130
 Why?
Double-Blind Method
1
2017
742
0.130
 Why?
Sensitivity and Specificity
4
2006
923
0.130
 Why?
Cells, Cultured
2
2017
1737
0.130
 Why?
Platinum Compounds
4
2008
10
0.130
 Why?
Aneurysm
1
1995
43
0.130
 Why?
DNA Primers
2
2006
225
0.130
 Why?
Algorithms
1
2019
697
0.130
 Why?
Phosphatidylinositol 3-Kinases
2
2014
153
0.130
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.120
 Why?
Mice
6
2021
6413
0.120
 Why?
Cyclohexanones
1
2014
7
0.120
 Why?
Obesity
5
2010
1197
0.120
 Why?
Apoptosis
2
2021
1300
0.120
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
15
0.120
 Why?
Embolization, Therapeutic
1
1995
98
0.120
 Why?
Transcriptional Activation
2
2019
134
0.120
 Why?
TOR Serine-Threonine Kinases
1
2014
85
0.120
 Why?
Genetic Association Studies
1
2014
136
0.120
 Why?
Introns
1
2013
49
0.120
 Why?
Hypercalcemia
1
1993
36
0.120
 Why?
Decision Support Techniques
2
2010
74
0.110
 Why?
Paclitaxel
4
2007
103
0.110
 Why?
Dose-Response Relationship, Drug
5
2008
1476
0.110
 Why?
Chromosome Mapping
3
2005
175
0.110
 Why?
Pyridines
1
2014
137
0.110
 Why?
Cell Transformation, Neoplastic
2
2006
200
0.110
 Why?
Brain Neoplasms
1
2016
284
0.110
 Why?
Dermatologic Surgical Procedures
1
1992
38
0.110
 Why?
Tomography, Emission-Computed
4
2005
53
0.110
 Why?
Groin
2
2002
16
0.110
 Why?
Keratinocytes
2
2006
96
0.110
 Why?
Models, Genetic
1
2012
209
0.100
 Why?
Exons
3
2007
105
0.100
 Why?
Pyrazoles
2
2023
110
0.100
 Why?
Laser Therapy
1
1992
91
0.100
 Why?
Glucose
1
2014
366
0.100
 Why?
RNA, Messenger
4
2021
1202
0.100
 Why?
Condylomata Acuminata
1
1991
5
0.100
 Why?
Heterozygote
2
2004
96
0.100
 Why?
Epithelium
2
2007
68
0.100
 Why?
Goserelin
1
2010
2
0.100
 Why?
Magnetic Resonance Imaging
3
2014
1604
0.100
 Why?
Decision Trees
1
2010
26
0.100
 Why?
Estrogen Antagonists
1
2010
19
0.100
 Why?
Models, Statistical
1
2012
259
0.100
 Why?
Ileal Diseases
1
1990
4
0.100
 Why?
Leiomyoma
1
1990
28
0.100
 Why?
Predictive Value of Tests
6
2010
1048
0.090
 Why?
Polymorphism, Restriction Fragment Length
1
2010
44
0.090
 Why?
Restriction Mapping
3
2006
32
0.090
 Why?
Epigenesis, Genetic
2
2019
399
0.090
 Why?
Cell Differentiation
2
2009
720
0.090
 Why?
Gastrointestinal Hemorrhage
1
1990
79
0.090
 Why?
Skin Transplantation
1
1990
50
0.090
 Why?
Colonic Neoplasms
2
2004
164
0.090
 Why?
Diagnosis, Differential
3
2020
1136
0.090
 Why?
Infusions, Intravenous
3
2006
231
0.090
 Why?
Endometrium
3
2019
43
0.090
 Why?
Down-Regulation
4
2020
388
0.090
 Why?
Fluorouracil
2
2006
61
0.090
 Why?
Urinary Bladder Diseases
1
2009
19
0.090
 Why?
Lymphatic Vessels
1
2009
47
0.090
 Why?
Lasers, Gas
1
2009
7
0.090
 Why?
Embolism, Air
1
2009
12
0.090
 Why?
Age Factors
4
2006
1195
0.090
 Why?
Genome, Human
2
2008
131
0.090
 Why?
Vaginal Neoplasms
2
2005
4
0.090
 Why?
Intestinal Diseases
1
2009
36
0.090
 Why?
Adenocarcinoma, Clear Cell
3
2019
37
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
 Why?
Fluorine Radioisotopes
1
2008
25
0.080
 Why?
Transcription, Genetic
4
2019
418
0.080
 Why?
Infertility, Female
1
2008
21
0.080
 Why?
Eimeria
1
2008
3
0.080
 Why?
Haplotypes
2
2017
105
0.080
 Why?
Ubiquitin
1
2008
51
0.080
 Why?
Polyethylene Glycols
2
2006
106
0.080
 Why?
Up-Regulation
2
2020
508
0.080
 Why?
Expressed Sequence Tags
1
2007
12
0.080
 Why?
Cricetinae
1
2008
209
0.080
 Why?
Tumor Burden
2
2021
142
0.080
 Why?
Cell Cycle Proteins
1
2009
199
0.080
 Why?
Infusion Pumps
1
1987
13
0.080
 Why?
Angiogenesis Inhibitors
2
2006
203
0.080
 Why?
Microdissection
1
2007
24
0.080
 Why?
Germ-Line Mutation
2
2006
68
0.080
 Why?
Fluorescent Antibody Technique
1
2007
141
0.080
 Why?
Diagnostic Imaging
1
2009
184
0.080
 Why?
MutS Homolog 2 Protein
5
2007
15
0.080
 Why?
Precancerous Conditions
2
2005
93
0.080
 Why?
Stromal Cells
1
2007
79
0.070
 Why?
Pelvic Floor
1
2007
47
0.070
 Why?
Aorta
3
2005
177
0.070
 Why?
Codon
2
2003
48
0.070
 Why?
Maximum Tolerated Dose
4
2010
37
0.070
 Why?
Organ Specificity
2
2018
126
0.070
 Why?
Lasers
1
2007
141
0.070
 Why?
Models, Biological
2
2008
823
0.070
 Why?
RNA, Double-Stranded
1
2006
21
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
18
0.070
 Why?
Tissue Fixation
1
2006
35
0.070
 Why?
Neutropenia
1
2007
120
0.070
 Why?
Intestinal Perforation
2
2006
26
0.070
 Why?
Recombinant Proteins
1
2008
569
0.070
 Why?
Specimen Handling
1
2006
62
0.070
 Why?
Pulmonary Embolism
1
1987
106
0.070
 Why?
Protein Kinases
1
2006
89
0.070
 Why?
Chromosomes, Artificial, Yeast
3
2000
6
0.070
 Why?
Head and Neck Neoplasms
2
2016
335
0.070
 Why?
Endometrial Hyperplasia
2
2002
14
0.070
 Why?
Papillomavirus Vaccines
1
2006
67
0.070
 Why?
Proportional Hazards Models
4
2010
431
0.070
 Why?
Abdomen
1
2006
83
0.070
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Recurrence
4
2010
690
0.060
 Why?
Probability
4
2007
176
0.060
 Why?
Neovascularization, Pathologic
1
2006
168
0.060
 Why?
Terminal Care
1
2005
56
0.060
 Why?
Camptothecin
2
2010
16
0.060
 Why?
Quinolines
1
2004
40
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
55
0.060
 Why?
Cell Adhesion Molecules
1
2005
87
0.060
 Why?
Amyloid
1
2004
29
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
250
0.060
 Why?
Receptors, Estrogen
2
2018
131
0.060
 Why?
Tissue Distribution
1
2004
178
0.060
 Why?
Genes, Viral
1
2003
43
0.060
 Why?
Abdomen, Acute
1
2003
6
0.060
 Why?
Lactones
1
2003
27
0.060
 Why?
Thrombospondins
1
2003
8
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
314
0.060
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
53
0.060
 Why?
Pyrimidinones
1
2023
19
0.060
 Why?
Obesity, Morbid
1
2004
88
0.060
 Why?
Male
10
2018
27312
0.060
 Why?
RNA, Viral
2
2016
141
0.060
 Why?
Neoplasms, Second Primary
1
2004
77
0.060
 Why?
Fibroma
1
2003
41
0.060
 Why?
Radiotherapy, Adjuvant
3
2010
66
0.060
 Why?
Congenital Abnormalities
1
2004
112
0.060
 Why?
Uterine Hemorrhage
1
2002
11
0.060
 Why?
Age of Onset
2
2004
116
0.060
 Why?
Clinical Competence
1
2006
446
0.060
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
DNA, Ribosomal
1
2002
28
0.050
 Why?
PTEN Phosphohydrolase
2
2019
61
0.050
 Why?
Acridines
1
2002
5
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
377
0.050
 Why?
AU Rich Elements
1
2021
2
0.050
 Why?
Pregnancy
3
2020
2620
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
 Why?
Complementary Therapies
1
2002
31
0.050
 Why?
Postmenopause
1
2002
102
0.050
 Why?
RNA Stability
1
2021
28
0.050
 Why?
Cytokine Receptor gp130
1
2021
13
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
26
0.050
 Why?
3' Untranslated Regions
1
2021
57
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.050
 Why?
Blotting, Northern
2
2001
108
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
26
0.050
 Why?
Blotting, Southern
3
2002
40
0.050
 Why?
Xenograft Model Antitumor Assays
1
2021
219
0.050
 Why?
Phosphoric Monoester Hydrolases
1
2000
24
0.050
 Why?
Uganda
1
2020
33
0.050
 Why?
Equipment Design
1
2001
318
0.050
 Why?
Risk Management
1
2000
34
0.050
 Why?
Physical Chromosome Mapping
1
2000
9
0.050
 Why?
Isoenzymes
1
2001
177
0.050
 Why?
Internship and Residency
1
2006
501
0.050
 Why?
Catheterization, Central Venous
1
2001
98
0.050
 Why?
Incidence
3
2007
1082
0.050
 Why?
beta Karyopherins
1
2019
4
0.050
 Why?
Logistic Models
2
2017
990
0.050
 Why?
Quality Improvement
1
2022
245
0.050
 Why?
Interviews as Topic
1
2001
319
0.050
 Why?
Acid Anhydride Hydrolases
1
1999
14
0.050
 Why?
Patient Discharge
1
2022
353
0.040
 Why?
Biopsy, Needle
3
2006
195
0.040
 Why?
Cell Survival
1
2021
657
0.040
 Why?
DNA Repair Enzymes
1
1999
50
0.040
 Why?
Adenosine Triphosphatases
1
1999
90
0.040
 Why?
Cell Nucleus
1
2019
203
0.040
 Why?
Molecular Targeted Therapy
1
2019
128
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Pregnancy Outcome
1
2020
249
0.040
 Why?
Regression Analysis
3
2006
445
0.040
 Why?
Coloring Agents
1
2019
84
0.040
 Why?
Histone Demethylases
1
2018
15
0.040
 Why?
Cystadenocarcinoma, Serous
1
2019
74
0.040
 Why?
Gene Dosage
1
2018
91
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2018
53
0.040
 Why?
Major Histocompatibility Complex
1
2017
14
0.040
 Why?
Leptin
1
2019
154
0.040
 Why?
Estradiol
1
2019
219
0.040
 Why?
Genotyping Techniques
1
2017
26
0.040
 Why?
Databases, Genetic
1
2018
101
0.040
 Why?
Receptors, Collagen
1
1997
3
0.040
 Why?
Receptors, Fibronectin
1
1997
4
0.040
 Why?
Chemokines
1
2017
96
0.040
 Why?
Transforming Growth Factor beta
1
2018
158
0.040
 Why?
Coculture Techniques
1
2017
160
0.040
 Why?
Integrins
1
1997
36
0.040
 Why?
Interferon-gamma
1
2018
195
0.040
 Why?
Chemotherapy, Adjuvant
2
2010
119
0.040
 Why?
Child
4
2018
7337
0.040
 Why?
Diet, High-Fat
1
2019
216
0.040
 Why?
Mass Screening
1
2000
370
0.040
 Why?
Hepatitis Viruses
1
2016
2
0.040
 Why?
Time Factors
4
2010
3212
0.040
 Why?
Longitudinal Studies
1
2019
746
0.040
 Why?
Epithelial Cells
2
2006
255
0.040
 Why?
Herpesviridae
1
2016
19
0.040
 Why?
Viruses
1
2016
21
0.040
 Why?
Host-Pathogen Interactions
1
2017
143
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
46
0.030
 Why?
DNA Replication
1
1997
152
0.030
 Why?
Central Nervous System Neoplasms
1
2016
57
0.030
 Why?
Plasmids
2
2001
180
0.030
 Why?
Sequence Analysis, RNA
1
2016
107
0.030
 Why?
Mice, Transgenic
1
2017
656
0.030
 Why?
Electrosurgery
1
1995
10
0.030
 Why?
Fibroblasts
1
2017
386
0.030
 Why?
Macrophages
1
2018
405
0.030
 Why?
CpG Islands
2
2008
104
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Prostatic Neoplasms
1
1998
415
0.030
 Why?
Arteries
1
1995
101
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
 Why?
Computational Biology
1
2016
231
0.030
 Why?
Cytokines
1
2017
676
0.030
 Why?
Treatment Failure
2
2008
139
0.030
 Why?
Multivariate Analysis
2
2009
643
0.030
 Why?
Missouri
2
2006
65
0.030
 Why?
Organs at Risk
1
2014
70
0.030
 Why?
Inclusion Bodies
1
1993
23
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
24
0.030
 Why?
Cell Division
2
1994
330
0.030
 Why?
Cell Death
1
2014
223
0.030
 Why?
Imaging, Three-Dimensional
1
2014
171
0.030
 Why?
Risk
2
2004
343
0.030
 Why?
Skin Physiological Phenomena
1
1992
19
0.030
 Why?
Guinea Pigs
1
1992
89
0.030
 Why?
Epidermis
1
1992
31
0.030
 Why?
Pelvis
2
2004
76
0.030
 Why?
Pedigree
2
2004
146
0.030
 Why?
Deoxyglucose
1
2012
37
0.030
 Why?
Regeneration
1
1992
72
0.030
 Why?
Colectomy
1
1992
33
0.030
 Why?
Computer Simulation
1
2012
332
0.030
 Why?
Premenopause
1
2010
26
0.020
 Why?
Sequence Deletion
2
2003
99
0.020
 Why?
Staurosporine
1
2010
14
0.020
 Why?
Quality-Adjusted Life Years
1
2010
70
0.020
 Why?
Pilot Projects
2
2004
808
0.020
 Why?
Anastomosis, Surgical
1
1990
72
0.020
 Why?
Amino Acid Sequence
2
2003
767
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
69
0.020
 Why?
Molecular Weight
1
1990
100
0.020
 Why?
Remission Induction
1
2010
221
0.020
 Why?
ras Proteins
2
2001
70
0.020
 Why?
Cicatrix
1
1990
43
0.020
 Why?
Hemoglobins
1
1990
126
0.020
 Why?
Staining and Labeling
1
1990
106
0.020
 Why?
Cost-Benefit Analysis
1
2010
291
0.020
 Why?
Chi-Square Distribution
1
2010
318
0.020
 Why?
Perioperative Care
1
2009
42
0.020
 Why?
Urinary Incontinence
1
2009
40
0.020
 Why?
Organoplatinum Compounds
1
2008
18
0.020
 Why?
Gene Knockdown Techniques
1
2009
125
0.020
 Why?
Vinblastine
1
2008
41
0.020
 Why?
Fetus
1
1990
227
0.020
 Why?
Life Style
1
2009
156
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
204
0.020
 Why?
Emotions
1
2009
168
0.020
 Why?
Demography
1
2007
99
0.020
 Why?
Cadherins
1
2007
72
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
151
0.020
 Why?
DNA Mismatch Repair
1
2006
17
0.020
 Why?
Waxes
1
2006
1
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
18
0.020
 Why?
NIH 3T3 Cells
1
2006
55
0.020
 Why?
Cell Line
1
1990
1153
0.020
 Why?
Immunoenzyme Techniques
2
2001
165
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
14
0.020
 Why?
Cryopreservation
1
2006
31
0.020
 Why?
Chromosomal Instability
1
2006
17
0.020
 Why?
Neoplasm, Residual
1
2007
166
0.020
 Why?
Skin
1
1990
469
0.020
 Why?
Genome, Viral
1
2006
100
0.020
 Why?
Nurse Practitioners
1
2006
42
0.020
 Why?
Mutation, Missense
1
2006
117
0.020
 Why?
Ovarian Cysts
1
2005
3
0.020
 Why?
Gynecology
1
2006
50
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Analysis of Variance
1
2007
635
0.020
 Why?
Transfection
1
2006
399
0.020
 Why?
Early Diagnosis
1
2006
96
0.020
 Why?
Medical Futility
1
2005
12
0.020
 Why?
Cyclophosphamide
1
2006
172
0.020
 Why?
Triage
1
2006
76
0.020
 Why?
Gene Expression
1
2008
664
0.020
 Why?
Leiomyosarcoma
1
2005
25
0.020
 Why?
Hospice Care
1
2005
27
0.020
 Why?
Cytodiagnosis
1
2005
44
0.020
 Why?
Health Services
1
2005
80
0.020
 Why?
Obstetrics
1
2006
89
0.020
 Why?
Phosphorylation
1
2006
614
0.020
 Why?
Lymphatic System
1
2004
15
0.020
 Why?
Penetrance
1
2004
7
0.020
 Why?
Microscopy, Electron, Transmission
1
2004
87
0.020
 Why?
Area Under Curve
1
2004
205
0.020
 Why?
Calcification, Physiologic
1
2004
42
0.020
 Why?
Laparotomy
1
2004
36
0.020
 Why?
Bryostatins
1
2003
1
0.020
 Why?
Macrolides
1
2003
17
0.010
 Why?
Ethanol
1
2006
322
0.010
 Why?
Genomic Instability
1
2004
95
0.010
 Why?
Thrombospondin 1
1
2003
7
0.010
 Why?
Genes, p16
1
2003
9
0.010
 Why?
Tamoxifen
1
2004
60
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Frameshift Mutation
1
2003
17
0.010
 Why?
Confidence Intervals
1
2003
167
0.010
 Why?
Liposomes
1
2003
53
0.010
 Why?
Mutagenesis, Insertional
1
2003
28
0.010
 Why?
Palliative Care
1
2005
188
0.010
 Why?
Administration, Oral
1
2004
459
0.010
 Why?
DNA Transposable Elements
1
2003
82
0.010
 Why?
Cytoskeletal Proteins
1
2003
58
0.010
 Why?
Body Weight
1
2005
578
0.010
 Why?
Physicians
1
2006
247
0.010
 Why?
beta Catenin
1
2003
102
0.010
 Why?
Prevalence
1
2006
1022
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
5
0.010
 Why?
Retinoblastoma Protein
1
2002
21
0.010
 Why?
Reference Values
1
2003
354
0.010
 Why?
Ifosfamide
1
2002
8
0.010
 Why?
Trans-Activators
1
2003
147
0.010
 Why?
Bleomycin
1
2002
37
0.010
 Why?
Hospitals, University
1
2002
89
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
74
0.010
 Why?
Equipment Failure
1
2001
70
0.010
 Why?
Nucleic Acid Hybridization
2
1991
54
0.010
 Why?
Age Distribution
1
2002
198
0.010
 Why?
Statistics, Nonparametric
1
2002
232
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
85
0.010
 Why?
Carcinoma, Small Cell
1
2001
28
0.010
 Why?
Genes, erbB-1
1
2001
9
0.010
 Why?
Outpatients
1
2002
123
0.010
 Why?
Hospitalization
1
2005
705
0.010
 Why?
Radiography
1
2002
524
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
92
0.010
 Why?
Genetic Linkage
1
2000
26
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
169
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
29
0.010
 Why?
DNA
1
2004
581
0.010
 Why?
Morbidity
1
2000
149
0.010
 Why?
Blotting, Western
1
2001
683
0.010
 Why?
Gene Deletion
1
2000
293
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
164
0.010
 Why?
Chromosomes, Bacterial
1
1998
17
0.010
 Why?
Cloning, Molecular
1
1998
198
0.010
 Why?
Infant
1
2006
3817
0.010
 Why?
Child, Preschool
1
2006
4146
0.010
 Why?
Drug Resistance, Multiple
1
1997
20
0.010
 Why?
Gene Frequency
1
1997
120
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
87
0.010
 Why?
United States
1
2007
5200
0.010
 Why?
Dimethyl Sulfoxide
1
1994
13
0.010
 Why?
Glycerol
1
1994
22
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
52
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
142
0.010
 Why?
Drug Carriers
1
1994
81
0.010
 Why?
Cell Cycle
1
1994
275
0.010
 Why?
Retroperitoneal Space
1
1991
24
0.010
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (620) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department